Muehlensiepen, Felix http://orcid.org/0000-0001-8571-7286
May, Susann http://orcid.org/0000-0002-3601-7432
Hadaschik, Katharina
Vuillerme, Nicolas http://orcid.org/0000-0003-3773-393X
Heinze, Martin http://orcid.org/0000-0003-3645-1033
Grahammer, Manuel http://orcid.org/0000-0003-1560-4459
Labinsky, Hannah
Boeltz, Sebastian http://orcid.org/0000-0001-5227-8707
Detert, Jacqueline
Petersen, Jana
Krönke, Gerhard http://orcid.org/0000-0002-7566-4325
Schett, Georg http://orcid.org/0000-0001-8740-9615
Knitza, Johannes http://orcid.org/0000-0001-9695-0657
Funding for this research was provided by:
Abaton GmbH
Deutsche Forschungsgemeinschaft (2886)
Medizinische Hochschule Brandenburg CAMPUS gGmbH
Article History
Received: 26 August 2022
Accepted: 27 September 2022
First Online: 14 October 2022
Declarations
:
: JK reports personal fees from ABATON GmbH. MG is founder and shareholder of ABATON GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This prospective trial was registered in the WHO International Clinical Trials Registry (DRKS00024205) on 2021/03/03 and approved by Ethics Committee of the Friedrich-Alexander University Erlangen-Nuremberg (Reg no. 21_21B) on 2021/02/03). Written informed consent was obtained from all study participants. All methods were performed in accordance with relevant guidelines and regulations/declaration of Helsinki. Informed consent was obtained from all subjects and/or their legal guardian(s) for study participation. This manuscript has been compiled in accordance with the Consolidated Criteria for Reporting Qualitative Research (COREQ) (Supplemental File 4).